Nanomedicine, Volume I: Basic Capabilities by Robert A. Freitas Jr. is now available in softcover for $89 + shipping. Click here for information or to purchase the book directly from Landes Bioscience . Molecular nanotechnology has been defined as the three-dimensional positional control of molecular structure to create materials and devices to molecular precision. The human body is comprised of molecules, hence the availability of molecular nanotechnology will permit dramatic progress in human medical services. More than just an extension of "molecular medicine," nanomedicine will employ molecular machine systems to address medical problems, and will use molecular knowledge to maintain and improve human health at the molecular scale. Nanomedicine will have extraordinary and far-reaching implications for the medical profession, for the definition of disease, for the diagnosis and treatment of medical conditions including aging, and ultimately for the improvement and extension of natural human biological structure and function. Nanomedicine , the technical book series, will be published in four Volumes over the course of several years. This website is the first commercial Internet domain exclusively devoted to nanomedicine and is also the permanent online home of the Nanomedicine book series. Volume I was published by Landes Bioscience in October 1999. Volume IIA was published by Landes Bioscience in October 2003. Volume IIB and Volume III will be published in future years. Visitors are encouraged to employ links to specific subsections of these Volumes in their own books, papers, or online discussions. All local URLs and anchored book links from this website will remain stable. Landes Bioscience is to be congratulated, not only for the tremendous range and quality of its publications but also for its generous and farsighted embrace of simultaneous web-based publication of the Nanomedicine book series , which will better enable debate on, and the evolution of, this work. By 2002, Landes Bioscience had ...
| Website | http://www.nanomedicine.com |
| Revenue | $4 million |
| Employees | View employees |
| Industry | Business Services General, Business Services |
| Competitors | Amgen, Genentech, Bristol Myers Squibb, Gilead Sciences, AstraZeneca, Novartis, Pfizer, Merck & Co., Inc., Roche, Johnson & Johnson +46 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Nanomedicine employee's phone or email?
The Nanomedicine annual revenue was $4 million in 2026.
The NAICS codes for Nanomedicine are [54171, 5417, 541713, 541, 54].
The SIC codes for Nanomedicine are [87, 873].